Hahn A F, Jones D L, Knappskog P M, Boman H, McLeod J G
Department of Clinical Neurological Sciences, London Health Science Center, University of Western Ontario, London, Canada N6A 5A5.
J Neurol Sci. 2006 Dec 1;250(1-2):62-70. doi: 10.1016/j.jns.2006.07.001. Epub 2006 Sep 6.
To characterize the specific autonomic disturbances underlying the cold-induced sweating syndrome (CISS), and to describe a novel genetic variant of this rare recessive disorder. The two not previously reported patients had similar dysmorphic features: abnormal facial appearance, high arched palate, low set rotated ears, flexion deformities of elbows and fingers and scoliosis. Most noticeable were their paradoxical sweat responses: cold ambient temperature induced a profuse sweating over the face, arms and trunk but not over the lower limbs; while in the heat very little sweating occurred primarily on the legs. Testing of autonomic functions demonstrated normal cardiovascular reflexes and postganglionic sympathetic efferent functions. Sural nerve morphology and number of unmyelinated fibers was normal and skin biopsies showed normal appearing eccrine sweat glands. MRI scans revealed no structural brain abnormalities. Oral clonidine, prescribed in one patient, completely suppressed cold-induced sweating. Observed clinical features matched those of two sisters reported from Israel and of two brothers reported from Norway. All six cases presented a similar phenotype. The Norwegian, Israeli and Canadian cases were homozygous or compound heterozygous, respectively, for mutations in the CRLF1 gene on chromosome 19p12 (CISS1). The Australian case, however, had no pathogenic sequence variants in the CRLF1 gene, but was compound heterozygous for mutations in the CLCF1 gene on chromosome 11q13.3 (CISS2).
The rare cold-induced sweating syndrome is genetically heterogeneous and is probably caused by central and peripheral impairment of sudomotor functions. This is the first detailed report on the clinical consequences of mutations in the CLCF1 gene in humans. Directions for medical therapies are outlined to achieve long term symptom control.
明确冷诱导出汗综合征(CISS)潜在的特定自主神经紊乱,并描述这种罕见隐性疾病的一种新的基因变异。这两名此前未报道过的患者具有相似的畸形特征:面部外观异常、高拱腭、低位旋转耳、肘部和手指屈曲畸形以及脊柱侧弯。最引人注目的是他们矛盾的出汗反应:寒冷的环境温度会导致面部、手臂和躯干大量出汗,但下肢无汗;而在炎热环境中,主要是腿部出汗很少。自主神经功能测试显示心血管反射和节后交感神经传出功能正常。腓肠神经形态和无髓纤维数量正常,皮肤活检显示小汗腺外观正常。MRI扫描未发现脑部结构异常。一名患者服用口服可乐定后,完全抑制了冷诱导出汗。观察到的临床特征与以色列报道的两名姐妹以及挪威报道的两名兄弟的特征相符。所有六例均表现出相似的表型。挪威、以色列和加拿大的病例分别在19号染色体p12区域的CRLF1基因(CISS1)发生纯合或复合杂合突变。然而,澳大利亚的病例在CRLF1基因中没有致病序列变异,但在11号染色体q13.3区域的CLCF1基因(CISS2)发生复合杂合突变。
罕见的冷诱导出汗综合征在基因上具有异质性,可能是由发汗运动功能的中枢和外周损害引起的。这是关于人类CLCF1基因突变临床后果的第一份详细报告。概述了实现长期症状控制的医学治疗方向。